Date: 2010-10-19 13:01:20

Lymphoma

Histone deacetylase inhibitor

Cutaneous T-cell lymphoma

Romidepsin

Vorinostat

Histone deacetylase

Merck & Co.

Mesothelioma

Targeted therapy

Medicine

Pharmacology

Orphan drugs

Mesothelioma Articles - Merck & Co: Zolinza becomes first app...

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 39,24 KB